Update of MS Coalition’s DMT Paper Now Available

In August 2014, MSAA posted a news item announcing that the Multiple Sclerosis Coalition (MSC) had published a paper detailing the current evidence that supports the FDA-approved disease-modifying therapies (DMTs) for the long-term treatment of multiple sclerosis (MS). This paper was written expressly for healthcare providers and the health-insurance industry.

Read News Article

Glatopa™ (glatiramer acetate injection) Approved for the Long-Term Treatment of Relapsing Forms of MS

On April 16, 2015, the United States Food and Drug Administration (FDA) approved Glatopa™ (glatiramer acetate injection) for the treatment of individuals with relapsing forms of multiple sclerosis (MS), including those who have experienced a first clinical episode and have magnetic resonance imaging (MRI) features consistent with MS.

Read News Article

Cooling Vests Help Individuals Living with MS Beat the Heat

Individuals living with multiple sclerosis (MS) often find that heat and humidity aggravate common MS symptoms. In addition to advice such as using air conditioning and sipping cool beverages throughout the day, individuals living with MS may also benefit from the use of special cooling equipment to help maintain an ideal body temperature.

Read News Article

MS Awareness Month Raises Awareness of Individuals Living with Multiple Sclerosis

For the more than 400,000 Americans living with multiple sclerosis (MS), the support of loved ones, care partners and organizations such as the Multiple Sclerosis Association of America (MSAA) is crucial to improving quality of life. To help increase awareness of this disease, MSAA is taking part in observing March as MS Awareness Month.

Read News Article

MSAA Wins 2015 Bronze Telly Award for Affordable Care Act Video

MSAA is proud to announce that its latest video, “What You Need To Know About The Affordable Care Act” was selected as a winner in the 36th Annual Telly Awards in the category of Health and Fitness! Winners of the Telly Awards represent the best work of the most respected advertising agencies, production companies, television stations, cable operators, and corporate video departments in the world.

Read News Article

Multiple Sclerosis Coalition Endorses AAN Position Statement

The member organizations of the Multiple Sclerosis Coalition (MSC) unanimously endorsed the American Academy of Neurology’s (AAN) position statement entitled Availability of Disease Modifying Therapies (DMT) for Treatment of Relapsing Forms of Multiple Sclerosis.

Read News Article

Swimming for Health and Wellness … and a Good Cause

Health experts tout swimming as one of the best all-around, total-body workouts. It builds both strength and cardiovascular endurance, and is well-suited for all ages and abilities.

Read News Article

Multiple Sclerosis Coalition Backs Data-Gathering Bill

The Multiple Sclerosis Coalition’s (MSC) entire membership is providing support for bipartisan legislation to establish a data system to track the incidence and prevalence of neurological diseases, including multiple sclerosis. The bill, introduced in the U.S. House of Representatives by Congressmen Michael C. Burgess, M.D., (R-TX), and Chris Van Hollen (D-MD), could lead to a better understanding of the disease and provide new disease targets.

Read News Article

Keep Your New Year’s Resolutions and Support a Good Cause

Exercising more often is a popular New Year’s resolution, but one that too often proves difficult to keep. But what if thousands of people living with multiple sclerosis (MS) were counting on you to keep that commitment?

Read News Article

Changes Made to Tecfidera’s Label

The United States Food and Drug Administration (FDA) recently made some changes to the product labeling for Tecfidera® (dimethyl fumarate). These changes instruct physicians on how to best prescribe the drug for their patients to minimize the potential for certain side effects and adverse events. The revisions are described below; please note that several of the definitions given are from MedlinePlus (from the National Institutes of Health).

Read News Article